Preferred Label : receptors, interleukin-6;
MeSH definition : Cell surface receptors that are specific for INTERLEUKIN-6. They are present on T-LYMPHOCYTES,
mitogen-activated B-LYMPHOCYTES, and peripheral MONOCYTES. The receptors are heterodimers
of the INTERLEUKIN-6 RECEPTOR ALPHA SUBUNIT and the CYTOKINE RECEPTOR GP130.;
MeSH synonym : receptors, il6; receptor, il6; receptor, il-6; il-6 receptor; il6 receptor; interleukin 6 receptor; receptor, interleukin 6; interleukin-6 receptors; interleukin 6 receptors; receptors, il-6; receptors, il 6; il 6 receptor; il6 receptors; il-6 receptors; il 6 receptors; receptors, interleukin 6; Interleukin-6 Receptor; Receptor, Interleukin-6;
MeSH annotation : DF: RECEPT IL 6;
Wikipedia link : https://en.wikipedia.org/wiki/Receptors, interleukin-6;
Is substance : O;
Origin ID : D019947;
UMLS CUI : C0063717;
Allowable qualifiers
- Automatic exact mappings (from CISMeF team)
- Currated CISMeF NLP mapping
- Indexing information
- Record concept(s)
- Related MeSH Supplementary Concept(s)
- See also (suggested by CISMeF)
- Semantic type(s)
- UMLS correspondences (same concept)
Cell surface receptors that are specific for INTERLEUKIN-6. They are present on T-LYMPHOCYTES,
mitogen-activated B-LYMPHOCYTES, and peripheral MONOCYTES. The receptors are heterodimers
of the INTERLEUKIN-6 RECEPTOR ALPHA SUBUNIT and the CYTOKINE RECEPTOR GP130.
https://www.inesss.qc.ca/fileadmin/doc/INESSS/COVID-19/Outil_clinique_Usage-Tocilizumab-Sarilumab.pdf
2021
false
false
true
Canada
French
Interleukin-6
quebec
tocilizumab
tocilizumab
sarilumab
sarilumab
treatment outcome
drug therapy, combination
glucocorticoids
adult
aged
Interleukin 6 receptor antagonist (disposition)
guidelines for drug use
receptors, interleukin-6
biological therapy
pneumonia, viral
coronavirus infections
antibodies, monoclonal, humanized
pandemics
COVID-19
---
https://www.hcsp.fr/explore.cgi/avisrapportsdomaine?clefr=1048
2021
France
COVID-19
practice guideline
Treatments
case management
interleukin-1
health planning guidelines
receptors, interleukin-6
therapeutics
interleukin-6
receptors, interleukin-1
Treatments
judgment
---
http://www.cri-net.com/fiches-pratiques-et-eSessions/dernieres-mises-a-jour/prise-encharge-anti-il6
2020
France
guideline
receptors, interleukin-6
has patient
interleukin-6
case management
interleukin inhibitors
Intraspinal abscess
---
https://www.inesss.qc.ca/fileadmin/doc/INESSS/COVID-19/COVID-19_INESSS_biotherapie_IL-1.pdf
2020
false
false
true
Canada
pneumonia, viral
coronavirus infections
Interleukin-6
quebec
siltuximab
siltuximab
tocilizumab
tocilizumab
sarilumab
sarilumab
treatment outcome
guideline
receptors, interleukin-6
biological therapy
interleukin-6
pneumonia, viral
coronavirus infections
pandemics
antibodies, monoclonal
antibodies, monoclonal, humanized
COVID-19
---
http://www.has-sante.fr/portail/jcms/c_1294163/roactemra-tocilizumab-inhibiteur-de-linterleukine-6
http://www.has-sante.fr/portail/jcms/c_1294071/roactemra-aji-synthese-09052012
http://www.has-sante.fr/portail/jcms/c_1250744/roactemra-09052012-avis-ct-11877
2012
false
France
French
evaluation of the transparency committee
tocilizumab
receptors, interleukin-6
tocilizumab
tocilizumab
arthritis, juvenile
child
treatment outcome
antibodies, monoclonal, humanized
antibodies, monoclonal, humanized
infusions, intravenous
drug therapy, combination
continuity of patient care
clinical trials as topic
drug monitoring
risk management
---
